In contrast, the present study elucidates the IRF5-STAT axis as an upstream transcriptional regulator of ESM1 from the endothelial perspective, expanding the regulatory network and providing a theoretical basis for potential SSH therapeutic strategies targeting endothelial dysfunction. This evidence concerns the gene IRF5 and endothelial dysfunction.